A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT06212999 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06212999
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-30
- Primary completion
- 2026-12-26
- Enrollment
- 617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.